Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis

Author:

Singh Puneetpal1ORCID,Kumar Nitin1,Singh Monica1,Kaur Manminder2,Singh Gurjinderpal3,Narang Amit4,Kanwal Abhinav5ORCID,Sharma Kirti1,Singh Baani1,Napoli Mario Di6ORCID,Mastana Sarabjit7ORCID

Affiliation:

1. Division of Molecular Genetics, Department of Human Genetics, Punjabi University, Patiala 147002, India

2. Department of Neurology, MK Neuro Centre, Patiala 147002, India

3. Department of Neurology, Bhatia Hospital Neuro and Multispecialty, Patiala 147002, India

4. Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), Bathinda 151005, India

5. Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bathinda 151005, India

6. Department of Neurological Service, Annunziata Hospital, Sulmona, 67039 L’Aquila, Italy

7. Human Genomics Laboratory, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough LE11 3TU, UK

Abstract

Atherosclerosis is the formation of plaque within arteries due to overt assemblage of fats, cholesterol and fibrous material causing a blockage of the free flow of blood leading to ischemia. It is harshly impinging on health statistics worldwide because of being principal cause of high morbidity and mortality for several diseases including rheumatological, heart and brain disorders. Atherosclerosis is perpetuated by pro-inflammatory and exacerbated by pro-coagulatory mediators. Besides several other pathways, the formation of neutrophil extracellular traps (NETs) and the activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome contribute significantly to the initiation and propagation of atherosclerotic plaque for its worst outcomes. The present review highlights the contribution of these two disturbing processes in atherosclerosis, inflammation and atherothrombosis in their individual as well as collaborative manner.

Funder

Council of Scientific and Industrial Research

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3